High incidence of false positive results in patients with other acute infections, using the LIAISON® SARS-CoV-2 commercial chemiluminescent micro-particle immunoassay for detection of IgG anti SARS-CoV-2 antibodies.,Journal of Clinical Microbiology

当前位置： X-MOL 学术 › J. Clin. Microbiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

High incidence of false positive results in patients with other acute infections, using the LIAISON® SARS-CoV-2 commercial chemiluminescent micro-particle immunoassay for detection of IgG anti SARS-CoV-2 antibodies.
Journal of Clinical Microbiology ( IF 9.4 ) Pub Date : 2020-08-26 , DOI: 10.1128/jcm.01352-20
Narjis Boukli ₁ , Melchior Le Mene ₂ , Aurélie Schnuriger _{3,

4,

5} , Nancy Stella Cuervo ₂ , Cécilia Laroche ₂ , Laurence Morand-Joubert _{2,

4,

6} , Joël Gozlan _{2,

4,

7}

Affiliation